Cervomed Stock Price History
CRVO Stock | 6.44 0.65 11.23% |
Below is the normalized historical share price chart for CervoMed extending back to July 03, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CervoMed stands at 6.44, as last reported on the 16th of March 2025, with the highest price reaching 6.76 and the lowest price hitting 5.40 during the day.
If you're considering investing in CervoMed Stock, it is important to understand the factors that can impact its price. CervoMed is very risky given 3 months investment horizon. CervoMed secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 3.09% are justified by taking the suggested risk. Use CervoMed Risk Adjusted Performance of 0.0598, downside deviation of 15.25, and Mean Deviation of 6.68 to evaluate company specific risk that cannot be diversified away.
At this time, CervoMed's Total Stockholder Equity is very stable compared to the past year. As of the 16th of March 2025, Common Stock Shares Outstanding is likely to grow to about 3.2 M, while Common Stock is likely to drop 6,199. . As of the 16th of March 2025, Price Earnings To Growth Ratio is likely to grow to 0.12, while Price To Sales Ratio is likely to drop 3.11. CervoMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 2016 | 200 Day MA 10.8872 | 50 Day MA 2.4564 |
CervoMed |
Sharpe Ratio = 0.1478
Best Portfolio | Best Equity | |||
Good Returns | CRVO | |||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
20.91 actual daily | 96 96% of assets are less volatile |
Expected Return
3.09 actual daily | 61 61% of assets have lower returns |
Risk-Adjusted Return
0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average CervoMed is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CervoMed by adding it to a well-diversified portfolio.
Price Book 1.1666 | Enterprise Value Ebitda 1.6373 | Price Sales 5.2803 | Shares Float 5.3 M | Wall Street Target Price 13.6667 |
CervoMed Stock Price History Chart
There are several ways to analyze CervoMed Stock price data. The simplest method is using a basic CervoMed candlestick price chart, which shows CervoMed price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 14, 2025 | 6.44 |
Lowest Price | December 17, 2024 | 1.94 |
CervoMed March 16, 2025 Stock Price Synopsis
Various analyses of CervoMed's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell CervoMed Stock. It can be used to describe the percentage change in the price of CervoMed from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of CervoMed Stock.CervoMed Price Action Indicator | 0.69 | |
CervoMed Price Daily Balance Of Power | 0.48 | |
CervoMed Price Rate Of Daily Change | 1.11 |
CervoMed March 16, 2025 Stock Price Analysis
CervoMed Stock Price History Data
The price series of CervoMed for the period between Mon, Dec 16, 2024 and Sun, Mar 16, 2025 has a statistical range of 10.01 with a coefficient of variation of 65.06. The prices are distributed with arithmetic mean of 2.65. The median price for the last 90 days is 2.23. The company had 2:3 stock split on 17th of August 2023. CervoMed issued dividends on 2018-12-14.Open | High | Low | Close | Volume | ||
03/16/2025 | 5.74 | 6.76 | 5.40 | 6.44 | ||
03/14/2025 | 5.74 | 6.76 | 5.40 | 6.44 | 8,983,318 | |
03/13/2025 | 7.79 | 7.97 | 5.62 | 5.79 | 58,289,743 | |
03/12/2025 | 2.40 | 6.84 | 2.37 | 6.17 | 158,888,717 | |
03/11/2025 | 2.16 | 2.37 | 1.92 | 2.36 | 622,347 | |
03/10/2025 | 2.18 | 2.32 | 2.13 | 2.22 | 774,234 | |
03/07/2025 | 2.14 | 2.24 | 2.14 | 2.21 | 35,523 | |
03/06/2025 | 2.13 | 2.17 | 2.10 | 2.15 | 28,573 | |
03/05/2025 | 2.13 | 2.18 | 2.09 | 2.16 | 34,650 | |
03/04/2025 | 2.14 | 2.18 | 2.01 | 2.12 | 90,046 | |
03/03/2025 | 2.24 | 2.30 | 2.14 | 2.14 | 48,123 | |
02/28/2025 | 2.17 | 2.27 | 2.12 | 2.24 | 56,558 | |
02/27/2025 | 2.20 | 2.26 | 2.12 | 2.18 | 64,302 | |
02/26/2025 | 2.18 | 2.25 | 2.11 | 2.22 | 42,495 | |
02/25/2025 | 2.24 | 2.31 | 2.17 | 2.17 | 77,581 | |
02/24/2025 | 2.27 | 2.31 | 2.17 | 2.24 | 63,109 | |
02/21/2025 | 2.35 | 2.36 | 2.25 | 2.28 | 36,504 | |
02/20/2025 | 2.31 | 2.38 | 2.20 | 2.33 | 77,408 | |
02/19/2025 | 2.28 | 2.38 | 2.17 | 2.30 | 164,686 | |
02/18/2025 | 2.34 | 2.34 | 2.14 | 2.23 | 97,075 | |
02/14/2025 | 2.21 | 2.37 | 2.20 | 2.33 | 125,786 | |
02/13/2025 | 2.19 | 2.23 | 2.15 | 2.19 | 37,421 | |
02/12/2025 | 2.10 | 2.20 | 2.06 | 2.18 | 27,667 | |
02/11/2025 | 2.19 | 2.21 | 2.07 | 2.13 | 97,592 | |
02/10/2025 | 2.22 | 2.27 | 2.18 | 2.19 | 34,757 | |
02/07/2025 | 2.24 | 2.30 | 2.19 | 2.21 | 62,978 | |
02/06/2025 | 2.28 | 2.45 | 2.22 | 2.23 | 155,060 | |
02/05/2025 | 2.30 | 2.32 | 2.22 | 2.31 | 63,929 | |
02/04/2025 | 2.26 | 2.31 | 2.25 | 2.30 | 39,189 | |
02/03/2025 | 2.21 | 2.34 | 2.21 | 2.27 | 103,036 | |
01/31/2025 | 2.28 | 2.38 | 2.21 | 2.26 | 209,088 | |
01/30/2025 | 2.27 | 2.33 | 2.21 | 2.25 | 76,648 | |
01/29/2025 | 2.27 | 2.33 | 2.15 | 2.28 | 101,173 | |
01/28/2025 | 2.20 | 2.31 | 2.16 | 2.27 | 144,643 | |
01/27/2025 | 2.27 | 2.35 | 2.20 | 2.22 | 211,571 | |
01/24/2025 | 2.27 | 2.35 | 2.25 | 2.31 | 111,372 | |
01/23/2025 | 2.17 | 2.34 | 2.15 | 2.27 | 160,975 | |
01/22/2025 | 2.16 | 2.24 | 2.12 | 2.18 | 155,868 | |
01/21/2025 | 2.11 | 2.22 | 2.08 | 2.18 | 98,938 | |
01/17/2025 | 2.12 | 2.15 | 2.06 | 2.11 | 69,280 | |
01/16/2025 | 2.14 | 2.14 | 2.03 | 2.11 | 78,939 | |
01/15/2025 | 2.12 | 2.17 | 2.07 | 2.08 | 75,379 | |
01/14/2025 | 2.04 | 2.15 | 2.00 | 2.13 | 122,836 | |
01/13/2025 | 2.11 | 2.17 | 1.99 | 2.04 | 215,946 | |
01/10/2025 | 2.19 | 2.19 | 2.05 | 2.11 | 183,471 | |
01/08/2025 | 2.30 | 2.30 | 2.16 | 2.18 | 145,601 | |
01/07/2025 | 2.27 | 2.43 | 2.25 | 2.31 | 266,234 | |
01/06/2025 | 2.31 | 2.37 | 2.21 | 2.34 | 413,100 | |
01/03/2025 | 2.24 | 2.43 | 2.24 | 2.33 | 277,493 | |
01/02/2025 | 2.40 | 2.40 | 2.22 | 2.23 | 238,832 | |
12/31/2024 | 2.35 | 2.41 | 2.17 | 2.34 | 236,214 | |
12/30/2024 | 2.40 | 2.51 | 2.35 | 2.39 | 318,265 | |
12/27/2024 | 2.40 | 2.49 | 2.33 | 2.40 | 280,152 | |
12/26/2024 | 2.21 | 2.45 | 2.18 | 2.40 | 479,087 | |
12/24/2024 | 2.25 | 2.25 | 2.19 | 2.22 | 131,697 | |
12/23/2024 | 2.20 | 2.36 | 2.14 | 2.21 | 294,968 | |
12/20/2024 | 2.21 | 2.28 | 2.07 | 2.23 | 364,888 | |
12/19/2024 | 1.94 | 2.32 | 1.94 | 2.23 | 1,047,189 | |
12/18/2024 | 1.95 | 2.07 | 1.87 | 2.00 | 829,188 | |
12/17/2024 | 1.87 | 1.95 | 1.80 | 1.94 | 862,490 | |
12/16/2024 | 1.87 | 2.10 | 1.86 | 1.95 | 1,220,495 |
About CervoMed Stock history
CervoMed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CervoMed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CervoMed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CervoMed stock prices may prove useful in developing a viable investing in CervoMed
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 3.1 M | 3.2 M | |
Net Loss | -5.2 M | -5.5 M |
CervoMed Quarterly Net Working Capital |
|
CervoMed Stock Technical Analysis
CervoMed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
All Next | Launch Module |
CervoMed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CervoMed's price direction in advance. Along with the technical and fundamental analysis of CervoMed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CervoMed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0598 | |||
Jensen Alpha | 1.43 | |||
Total Risk Alpha | 4.12 | |||
Sortino Ratio | 0.0919 | |||
Treynor Ratio | 1.03 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share | Quarterly Revenue Growth 0.271 | Return On Assets | Return On Equity |
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.